Healthcare

2020 DSCSA Regulatory Update Verification for Pharmacies and Wholesalers

In light of the disruption brought to the pharmaceutical industry by the COVID-19 pandemic, the FDA recently issued updated guidance regarding its enforcement of key DSCSA verification requirements. As a service to the industry, Dwight de Vera, our General Manager, Healthcare Intelligence Solutions, provides a brief but insightful analysis of the FDA’s latest action in the video below.

• Read more about 2020 DSCSA Regulatory Update Verification for Pharmacies and Wholesalers

DSCSA Mini-Panel: Counterfeit Mitigation

Maintaining patient safety -- through the mitigation of counterfeit medications -- is getting a boost as systemic protective measures are quickly coming online throughout the healthcare ecosystem. However, while serialization will eventually enable the validation of saleable products, the threat to public health from fraudulent drugs has hardly disappeared. Watch this video with industry experts from Inmar for a brief take on the current situation.

• Read more about DSCSA Mini-Panel: Counterfeit Mitigation

DSCSA Mini-Panel: Inventory Accuracy

Optimizing pharmaceutical inventory accuracy isn’t about making best use of storage space. It’s critical, and often complex, asset management that’s essential to maintaining both efficient operations and regulatory compliance. Get a quick, fresh perspective on this important healthcare business function in this video featuring industry experts from Inmar.

• Read more about DSCSA Mini-Panel: Inventory Accuracy

DSCSA Mini-Panel: Recall Management

Drug recalls, as often as they occur, are not “business-as-usual” for stakeholders in the healthcare ecosystem. Pharma manufacturers, retail pharmacies and health systems each face unique challenges with every market action -- and each require individualized assistance in responding. Check out this video to get the “topline” on recall requirements and the help available from Inmar’s experts.  

• Read more about DSCSA Mini-Panel: Recall Management

What Pharma Manufacturers Need to Know about Consumer Drug Take-Back

As jurisdictions across the U.S. continue implementing and enforcing disparate legislation mandating drug take-back programs, the burden of funding and execution for these programs has fallen upon pharmaceutical manufacturers. 

• Read more about What Pharma Manufacturers Need to Know about Consumer Drug Take-Back

2020 Consumer Drug Take-Back Virtual Press Event Recap and Video

The diversion and misuse of prescription medications poses a serious threat to public health in California and the nation. Now, authorities in some states are reporting rises in overdoses during the COVID-19 crisis, potentially from the resulting stress and isolation. It is more important than ever that consumers have a safe and convenient means to dispose of unwanted medications. 

• Read more about 2020 Consumer Drug Take-Back Virtual Press Event Recap and Video

INSIGHTS INTO RX INDUSTRY ACTIVITY: 8/6/2020

Recent analysis of industry activity performed using our new PrescriptiveIQ for Healthcare solution revealed several significant trends driven by, and developing out of, the COVID-19 pandemic.  

• Read more about INSIGHTS INTO RX INDUSTRY ACTIVITY: 8/6/2020

Inmar Intelligence Partners with The National Stewardship Action Council to Launch Statewide LifeInCheck™ Consumer Drug Take-Back Program in California

The collaboration expands access to safe medicine disposal kiosks with the addition of over 320 kiosk placements in grocery locations throughout California. Inmar Intelligence, a data-driven technology-enabled services company, has partnered with the National Stewardship Action Council (NSAC) to launch a statewide LifeInCheck™ consumer drug take-back program in California, expanding upon the States’ current medicine disposal infrastructure. 

• Read more about Inmar Intelligence Partners with The National Stewardship Action Council to Launch Statewide LifeInCheck™ Consumer Drug Take-Back Program in California

Insights into Rx Industry Activity

Recent analysis of industry activity performed using our new PrescriptiveIQ for Healthcare solution revealed several significant trends driven by, and developing out of, the  COVID-19 pandemic.

• Read more about Insights into Rx Industry Activity